Position in CDNA
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$2,596,578
New position
Shares Held
91,108
first reported quarter
Ownership
0.176%
of shares outstanding
% of Portfolio
0.31%
of 13F equity value
Holder Rank
#71
of 225 holders
Holding Since
Jun 2026
1 quarter on record
Voting authority
Sole 0%
Shared 0%
None 100%
Position in Diagnostics & Research
Healthcare · as of Jun 30, 2026Kera Capital Partners, Inc. holds $8,451,773 across 12 Diagnostics & Research names. CDNA ranks #1 (30.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | CDNA |
CareDx, Inc.
This page
|
91,108 | $2,596,578 | |
| 2 | ILMN |
Illumina, Inc.
|
6,640 | $1,167,511 | |
| 3 | A |
Agilent Technologies, Inc.
|
7,191 | $955,180 | |
| 4 | IQV |
Iqvia Holdings Inc.
|
3,772 | $728,825 | |
| 5 | CRL |
Charles River Laboratories International, Inc.
|
2,026 | $459,476 | |
| 6 | MEDP |
Medpace Holdings, Inc.
|
859 | $454,917 | |
| 7 | DGX |
Quest Diagnostics Inc
|
1,999 | $423,688 | |
| 8 | MTD |
Mettler Toledo International Inc/
|
292 | $373,032 |
All Filings in CDNA
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $2,596,578 | 91,108 | Shares | Sole | 2026-08-14 | |
| No filing history on record for this holder in this stock. | ||||||